MetLife Investment Management’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-11,530
| Closed | -$46.1K | – | 2386 |
|
|
2020
Q1 | $46.1K | Sell |
11,530
-13,629
| -54% | -$54.5K | ﹤0.01% | 2230 |
|
|
2019
Q4 | $213K | Hold |
25,159
| – | – | ﹤0.01% | 1945 |
|
|
2019
Q3 | $172K | Hold |
25,159
| – | – | ﹤0.01% | 2027 |
|
|
2019
Q2 | $210K | Buy |
25,159
+11,448
| +83% | +$95.4K | ﹤0.01% | 2003 |
|
|
2019
Q1 | $126K | Hold |
13,711
| – | – | ﹤0.01% | 2226 |
|
|
2018
Q4 | $150K | Hold |
13,711
| – | – | ﹤0.01% | 2077 |
|
|
2018
Q3 | $191K | Hold |
13,711
| – | – | ﹤0.01% | 2108 |
|
|
2018
Q2 | $146K | Buy |
+13,711
| New | +$146K | ﹤0.01% | 2072 |
|